Advocacy, Education and Lobbying
Read about how SITC has been active in advocacy, education and lobbying.
SITC, in partnership with FDA and NCI/NIH, addresses regulatory issues relating to the field of cancer immunotherapy.
Standards and Quality of Care
SITC various task forces and committees are dedicated to developing standards and quality of care guidelines for clinicians.
Value of Immunotherapy
To facilitate dialogue on the value of immunotherapy, SITC hosts annual programs where leaders in the field discuss the latest in cancer immunotherapy.